Rationale and design of three ongoing phase 1/2 trials of modakafusp alfa, an innate immunity enhancer, in patients with multiple myeloma: The innovate clinical development program Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Mian, Hira
  • Touzeau, Cyrille
  • Holstein, Sarah
  • Kingsley, Edwin
  • Vogl, Dan
  • Zuniga, Richard
  • Kim, Kihyun
  • Suryanarayan, Kaveri
  • Wang, Shining
  • Thesillat-Versmee, Laura
  • Liu, Yuyin
  • Chen, Tian
  • Zhang, Yefei
  • Parot, Xavier
  • Lee, Hans

publication date

  • September 2023